Defining Operational UV-C Dose Requirements for Autonomous Disinfection of Clinically Relevant Pathogens Across Healthcare and High-Touch Surfaces

Background: Autonomous ultraviolet-C (UV-C) disinfection systems are increasingly used to supplement manual environmental cleaning, yet evidence-based guidance defining pathogen-specific UV-C dose requirements across representative surfaces remains limited. Aim: To characterize operational UV-C dose requirements for clinically relevant pathogens across diverse high-touch and healthcare surfaces and determine how experimentally derived microbial inactivation can inform operational exposure parameters. Methods: SARS-CoV-2, adenovirus, Pseudomonas aeruginosa, Staphylococcus aureus, Klebsiella pneumoniae, Enterococcus faecalis, Candida auris, and Clostridioides difficile spores were exposed to defined UV-C doses on representative high-touch materials or stainless steel under standardized conditions, including a 10% fetal bovine serum organic soil challenge. Microbial inactivation was quantified by viable recovery. Dose-response analysis and operational modelling were used where supported by the experimental data. Findings: UV-C exposure significantly reduced viable recovery of all pathogens, with substantial differences in the exposure conditions associated with microbial inactivation. SARS-CoV-2 exhibited substantial inactivation at doses as low as 2.6 mJ/cm2, whereas the highest evaluated doses were 1,800 mJ/cm2 for C. difficile spores and 3600 mJ/cm2 for C. auris. For C. auris, multi-dose data estimated that approximately 1,410 mJ/cm2 was associated with a 2-log10 reference reduction, enabling distance-dependent exposure-time predictions. Conclusion: Experimentally quantified UV-C exposures produced substantial microbial inactivation across diverse pathogen classes and surfaces. Integrating delivered dose with microbial reduction provides a quantitative framework for translating laboratory efficacy into operational parameters for autonomous UV-C disinfection.